Takeda Pharmaceutical Company Limited Current Receivables From Contracts With Customers
Takeda Pharmaceutical Company Limited (TKPHF) had Current Receivables From Contracts With Customers of JPY 651.41 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Receivables
ifrs-full:CurrentReceivablesFromContractsWithCustomers · last filed 2025-06-25
- 2025-03-31: Current Receivables From Contracts With Customers 651.41B JPY.
- 2024-03-31: Current Receivables From Contracts With Customers 612.44B JPY.
- 2023-03-31: Current Receivables From Contracts With Customers 575.43B JPY.
- 2022-03-31: Current Receivables From Contracts With Customers 617.52B JPY.
| Period end | Current Receivables From Contracts With Customers |
|---|---|
| 2025-03-31 | 651.41B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 612.44B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 575.43B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 617.52B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 707.49B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 670.71B JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 657.68B JPY 20-F · filed 2020-06-24 |
| 2018-04-01 | 360.83B JPY 20-F · filed 2019-06-27 |